Parkinson’s patients ‘owed’ more research into using cancer drug as treatment

News

Author: AdminPublished: 2 November 2015

Prep: Cook: Serves:

A small clinical trial showed that cancer drug Nilotinib may reverse late-stage Parkinson’s disease, potentially enabling participants to speak and walk again for the first time in years.

President and co-founder of The Cure Parkinson’s Trust, Tom Isaacs, has called for a close follow up of this small study to ensure that any opportunity for a breakthrough in the treatment of Parkinson’s is not missed.

Isaacs said: ‘Nilotinib is a case in point. When people with Parkinson’s volunteer for clinical trials and feel the type of marked improvements to their symptoms and wellbeing as those reported in this study, we owe it to them, and indeed everyone, to follow the results up as quickly and as rigorously as possible.”

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

That moment the doc drops the P bomb

What it’s like to be diagnosed with Parkinson’s at 29 years old

Painting a picture of life with Parkinson’s

Australian artist Timothy John describes his work

“Since being diagnosed with Parkinson’s, my world has expanded”

The latest in our monthly series profiling WPC2019 bloggers

Could a sea sponge support the search for Parkinson’s disease treatments?

How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Parkinson’s patients ‘owed’ more research into using cancer drug as treatment

News

Author: AdminPublished: 2 November 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

That moment the doc drops the P bomb

Perspectives

Painting a picture of life with Parkinson’s

Interviews

“Since being diagnosed with Parkinson’s, my world has expanded”

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Parkinson’s patients ‘owed’ more research into using cancer drug as treatment

News

Author: AdminPublished: 2 November 2015

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

That moment the doc drops the P bomb

Perspectives

Painting a picture of life with Parkinson’s

Interviews

“Since being diagnosed with Parkinson’s, my world has expanded”

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Sign in